highly significantp < 0.0001
For SFTPA2, expression increased 5.13-fold in the severe group compared to the asymptomatic COVID-19-positive patient group and 50.02-fold compared to the mild group, both changes being highly significant ( p < 0.0001).
For SFTPA2, expression increased 5.13-fold in the severe group compared to the asymptomatic COVID-19-positive patient group and 50.02-fold compared to the mild group, both changes being highly significant ( p < 0.0001).